Pura Vida Investments’s STAAR Surgical STAA Stock Holding History

Pura Vida Investments’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-77,500	Closed	-$2.42M	–	69
2023 Q4	$2.42M	Buy	77,500 +7,500	+11%	+$269K	0.37%	33
2023 Q3	$2.81M	Buy	+70,000	New	+$3.28M	0.53%	48
2023 Q2	–	Sell	-110,000	Closed	-$7.03M	–	95
2023 Q1	$7.03M	Sell	110,000 -315,000	-74%	-$20.6M	0.71%	38
2022 Q4	$20.6M	Buy	425,000 +55,000	+15%	+$3.45M	1.06%	24
2022 Q3	$26.1M	Buy	+370,000	New	+$31.7M	1.51%	19
2022 Q2	–	Sell	-170,000	Closed	-$13.6M	–	270
2022 Q1	$13.6M	Buy	170,000 +9,900	+6%	+$737K	0.44%	56
2021 Q4	$14.6M	Sell	160,100 -4,900	-3%	-$526K	0.53%	49
2021 Q3	$21.2M	Buy	+165,000	New	+$23.1M	0.65%	37
2020 Q1	–	Sell	-327,000	Closed	-$11.5M	–	129
2019 Q4	$11.5M	Buy	+327,000	New	+$10.8M	1.01%	35

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's STAA Position: Q3 2024 in Review

Pura Vida Investments sold out of STAAR Surgical (STAA) in Q3 2024, closing a stake of 30,000 shares — an estimated $1.43M sold.

Pura Vida Investments first reported a position in STAA in Q2 2015 and held it in 21 quarters. The position peaked at $30.3M in Q1 2021. 236 funds tracked by Wall St. Rank hold STAA as of Q3 2024.

Pura Vida Investments reported no remaining STAAR Surgical position as of Q3 2024 after selling out during the quarter.
Pura Vida Investments sold 30,000 STAAR Surgical shares in Q3 2024, an estimated $1.43M.
Pura Vida Investments first reported a position in STAAR Surgical in Q2 2015 and held it in 21 quarters.
Pura Vida Investments's STAAR Surgical position peaked at $30.3M in Q1 2021.
236 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2024.

Based on Pura Vida Investments's 13F filing for Q3 2024, filed 14 Nov 2024.